India Funding Roundup & Key Business News - June 8, 2026: Immuneel Therapeutics Raises Rs 100 Cr Series B, GPS Renewables Closes Rs 635 Cr Series C
Here's your daily funding and key business news roundup for June 8, 2026: Monday opened the week with health and climate leading the capital flow, as cancer-focused biotech Immuneel Therapeutics raised over Rs 100 crore in a Series B and biogas infrastructure company GPS Renewables closed a Rs 635 crore Series C.
On the business front, Curefoods shelved its IPO plans amid market volatility, Cars24 onboarded Infosys CFO Jayesh Sanghrajka as independent director, and edtech startup Klassroom received BSE in-principle approval for its SME IPO.
Daily Indian Startup Funding Digest - 8 June 2026
| Startup | Sector | Funding | Round | Lead Investor |
|---|---|---|---|---|
| GPS Renewables | Clean Energy / Biogas | Rs 635 Cr (~$66 Mn) | Series C | PixelSky Capital + Sojitz Corporation |
| Immuneel Therapeutics | Biotech / Cancer Therapy | Rs 100 Cr+ (~$10.5 Mn) | Series B | Singularity AMC, Rainmatter, HNIs |
| Wholeleaf | Pain Therapeutics / Healthtech | Rs 7.5 Cr (in talks) | Fresh Round | IPV, Benzai 10 Capital |
GPS Renewables Raises Rs 635 Crore in Series C Round
Bengaluru-based renewable natural gas company GPS Renewables has raised Rs 635 crore in a Series C round. PixelSky Capital led a Rs 125 crore equity tranche with participation from Spectrum Impact Family Office. Additionally, its asset-holding platform Arya received Rs 200 crore from a leading Korean conglomerate, following an earlier Rs 310 crore investment from Sojitz Corporation.
With annual revenue of approximately Rs 1,000 crore and over 800 employees, the company has more than 30 operational or near-complete projects and visibility on 200+ CBG projects with oil marketing companies.
Immuneel Therapeutics Raises Over Rs 100 Crore in Series B
Cancer-focused biotech startup Immuneel Therapeutics has raised over Rs 100 crore ($10.5 million) in a Series B from Singularity AMC, Rainmatter by Zerodha, HNIs, and existing investors including Kiran Mazumdar-Shaw, Eight Roads Ventures, and F-Prime Capital.
Founded in 2018 by Kiran Mazumdar-Shaw, Siddhartha Mukherjee, and Kush Parwar, the Bengaluru-based startup recently commercialised Qartemi, described as India's first approved CAR-T therapy for Non-Hodgkin Lymphoma and leukaemia. Proceeds will expand GMP manufacturing, accelerate commercialisation, and support expansion across Asia Pacific and the Middle East.
Wholeleaf in Advanced Talks to Raise Rs 7.5 Crore
Gurugram-based pain therapeutics startup Wholeleaf is in advanced talks to raise Rs 7.5 crore from IPV and Benzai 10 Capital. Founded in 2021 by Shivraj Sharma, Wholeleaf leads the cannabinoid pain therapeutics category in India with oral tinctures and topical formulations for chronic conditions including migraines, arthritis, fibromyalgia, and menstrual pain.
The company reports an ARR of Rs 18 crore and is present across nearly 2,000 retail outlets in Delhi-NCR, with plans to expand to 5,000 to 7,000 outlets this year. It has raised Rs 5 crore to date, including from Shark Tank India investors Aman Gupta, Kanika Tekriwal, and Namita Thapar.
KEY BUSINESS NEWS
Curefoods Puts IPO Plans on Hold Amid Market Volatility
Cloud kitchen operator Curefoods has reportedly shelved its IPO plans due to volatile market conditions, joining Flipkart and PhonePe in deferring listing timelines. The company had received SEBI approval for a proposed Rs 800 crore IPO after filing draft papers in October 2025.
Founded by Ankit Nagori, Curefoods operates food brands including EatFit, CakeZone, Nomad Pizza, Frozen Bottle, and Krispy Kreme. The company posted revenue of Rs 745.8 crore in FY25, up from Rs 585.1 crore in FY24, while narrowing losses to Rs 170 crore.
Cars24 Onboards Infosys CFO Jayesh Sanghrajka as Independent Director
IPO-bound used car marketplace Cars24 has appointed Infosys CFO Jayesh Sanghrajka as an independent director, elevating his existing role as an audit committee member since 2021. Sanghrajka has been with Infosys for nearly 14 years, heading M&A, stakeholder management, and post-merger integration. The move comes as Cars24 targets a public listing within the next six to twelve months.
The startup reported an 18% year-on-year rise in adjusted net revenue to Rs 651 crore in H1 FY26, while trimming its adjusted EBITDA loss by 36% to Rs 162 crore.
Klassroom Gets BSE In-Principle Approval for SME IPO
Edtech startup Fusion Klassroom has received in-principle approval from the Bombay Stock Exchange for its proposed IPO on the SME platform. The issue comprises a fresh issue of up to 19.89 lakh equity shares and an OFS of up to 4.66 lakh shares by promoters and angel investors. Founded in 2016 by Alka Javeri, Dhruv Javeri, and Dhumil Javeri, Klassroom operates a hybrid AI-powered edtech platform with offline partner centres for Classes 8 to 12.
The company reported Rs 12.4 crore in revenue and nearly Rs 4 crore in net profit for the six months ended September 2025.
Muskaan Kapoor
